Skip to main content

Table 4 The mean effectiveness rates and annual costs of TOZ versus ADM and ETC

From: Cost-consequence analysis of tocilizumab versus adalimumab and etanercept among rheumatoid arthritis patients in Saudi Arabia: a single-center study

 

TOZ

ADM and ETC

Mean difference (95% Confidence interval)

Mean cost of treatment (USD)

16,945.26 ± 3,113.04

6,857.38 ± 3,113.04

10,087.88 (9,494.5011,441.63)

Mean effectiveness rate of CRP

4.34 ± 10.75

0.38 ± 8.79

3.96 (1.611–4.96)

Mean effectiveness rate of ESR

12.73 ± 30.88

1.52 ± 18.09

11.2108 (10.2818.11 )